Supercritical fluid fabrication of components for a sustained-release injectable risperidone dose form
- Authors: Bagratashvili V.N.1, Bogorodskii S.E.1, Egorov A.M.2, Krotova L.I.1, Popov V.K.1, Sevast’yanov V.I.3
-
Affiliations:
- Institute of Laser and Information Technologies
- Department of Chemistry
- Federal Research Center of Transplantology and Artificial Organs
- Issue: Vol 10, No 7 (2016)
- Pages: 1123-1130
- Section: Article
- URL: https://journals.rcsi.science/1990-7931/article/view/198554
- DOI: https://doi.org/10.1134/S1990793116070022
- ID: 198554
Cite item
Abstract
The process of supercritical fluid encapsulation of pharmaceutical grade risperidone into bioresorbable D,L-polylactide microparticles via the PGSS (Particles from Gas-Saturated Solutions) method was examined. Micronization and changes in the morphology of risperidone crystals during its encapsulation into a polymer plasticized with supercritical carbon dioxide were experimentally observed. This result made it possible to prepare the polymer structures of various dispersities (from 10 to 100 μm) and morphologies containing up to 40 wt % of risperidone without the use of organic solvents. The kinetics of release of risperidone from polymer microparticles in saline solution was studied by UV spectrophotometry. It was shown that the use of D,L-polylactides of various molecular weights makes it possible to achieve a controlled increase in the time of release of risperidone from bioresorbable polymer particles prepared via the PGSS technique up to ten days.
About the authors
V. N. Bagratashvili
Institute of Laser and Information Technologies
Email: popov@laser.ru
Russian Federation, Moscow
S. E. Bogorodskii
Institute of Laser and Information Technologies
Email: popov@laser.ru
Russian Federation, Moscow
A. M. Egorov
Department of Chemistry
Email: popov@laser.ru
Russian Federation, Moscow
L. I. Krotova
Institute of Laser and Information Technologies
Email: popov@laser.ru
Russian Federation, Moscow
V. K. Popov
Institute of Laser and Information Technologies
Author for correspondence.
Email: popov@laser.ru
Russian Federation, Moscow
V. I. Sevast’yanov
Federal Research Center of Transplantology and Artificial Organs
Email: popov@laser.ru
Russian Federation, Moscow
Supplementary files
